An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica FDA Issues Warning: Compounding Certain Bulk Drug Substances May Pose Major Legal and Patient Safety Risks Lengea The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University FDA mulls compounding for peptides previously flagged over safety risks BioSpace The Peptide Boom Is Getting Out of Hand The Atlantic